Literature DB >> 29891230

Renal complications during pregnancy: In the hypertension spectrum.

Angela Pauline P Calimag-Loyola1, Edgar V Lerma2.   

Abstract

In pregnancy, there are numerous changes which occur to accommodate the needs of both the fetus and placenta. These changes present us with a unique set of clinical challenges particularly in the setting of any disease processes occurring during pregnancy. It is essential to understand that the systems profoundly affected are the cardiovascular and renal systems. The most predominant disease process occurring in pregnancy affecting both the cardiovascular and renal system is the spectrum of hypertensive disorders specifically pre-eclampsia. Due to its high incidence worldwide, it is considered as the most common cause of infant and maternal morbidity and mortality. While the international definition, classification scheme and diagnostic criteria for Hypertensive Disorders of Pregnancy still must be agreed upon, hypertension has been the mandatory feature for all established guidelines. Pre-eclampsia particularly the severe form which is recognized as HELLP (Hemolysis, Elevated Liver enzymes and Low Platelet count) syndrome is the primary cause of acute kidney injury in pregnancy. In this review, we would primarily discuss the hemodynamic and vascular changes, anatomical and physiologic renal adaptations occurring during normal pregnancy and the complications which arise in the setting of hypertensive diseases. Mainly focusing on the pre-eclampsia spectrum, since knowledge of these is of clinical importance not only in understanding its role in the disease process but more so its implications for prevention, screening, diagnosis, and management.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Eclampsia; Hypertension; Kidney disease; Pre-eclampsia; Pregnancy; Renal complications

Mesh:

Year:  2018        PMID: 29891230     DOI: 10.1016/j.disamonth.2018.03.001

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  3 in total

1.  Efficacy of nifedipine tablets plus aspirin in patients with gestational hypertension and the effect on coagulation function and hemorheology.

Authors:  Xuejing Yin; Zhanhui Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model.

Authors:  Álvaro Santana-Garrido; Claudia Reyes-Goya; Pablo Espinosa-Martín; Luis Sobrevia; Luis M Beltrán; Carmen M Vázquez; Alfonso Mate
Journal:  Antioxidants (Basel)       Date:  2022-08-19

3.  Expression and role of miR-338-3p in peripheral blood and placenta of patients with pregnancy-induced hypertension.

Authors:  Jun Li; Yan Wu; Hui Liu
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.